Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Australia
Clinical trial register · Australia

Clinical Trials in Australia

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3379 matching records held by the registry are in this view. Synced 18 Nov 2026, 03:18 UTC
3379
Studies in scope
all four open statuses
1825
Recruiting now
open to new participants
783
Lead sponsors
across recruiting studies
Top sites
Melbourne 30 Sydney 6 Brisbane 3 Adelaide 3 Camperdown 2

Trials in this register

31 of 3379 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Not yet open
Peter MacCallum Cancer Centre, Australia
Phase 2
30
Melbourne
2026-12
Not yet open
Evaluation of FLT3L Armoured CAR T-cells in HER2 Expressing Malignant Diseases in Adults
NCT07939230HER-2 Positive Advanced Solid Tumors, HER-2 Positive Breast Cancer, HER-2 Positive Advanced Gastric Cancer, HER-2 Positive Colorectal Cancer
Peter MacCallum Cancer Centre, Australia
Phase 1
12
Melbourne
2026-11-21
Not yet open
Peter MacCallum Cancer Centre, Australia
Phase 2
20
Melbourne
2026-06
Recruiting
Peter MacCallum Cancer Centre, Australia
Phase 1
12
Melbourne
2026-05
Not yet open
Peter MacCallum Cancer Centre, Australia
Observational
75
Camperdown, Sydney, Adelaide, Hobart, Box Hill, Clayton, Melbourne, Nedlands
2026-04-08
Recruiting
Novel Treatment of Radiation Associated Dysphagia With Statins
NCT07217938Radiation-associated Dysphagia, Head &Amp; Neck Cancer
Peter MacCallum Cancer Centre, Australia
Phase 2
48
Melbourne
2025-12-05
Recruiting
Peter MacCallum Cancer Centre, Australia
Not applicable
214
Melbourne
2025-12-03
Active, closed
Peter MacCallum Cancer Centre, Australia
Not applicable
25
Melbourne
2025-11-24
Recruiting
Peter MacCallum Cancer Centre, Australia
Observational
80
Sydney, Brisbane, Cairns, Melbourne
2025-09-11
Not yet open
Peter MacCallum Cancer Centre, Australia
Not applicable
30
Melbourne
2025-09-04
Recruiting
Peter MacCallum Cancer Centre, Australia
Phase 2
40
Melbourne
2025-05-05
Recruiting
Peter MacCallum Cancer Centre, Australia
Phase 2
40
Camperdown, Westmead, Herston, Melbourne, Murdoch
2024-05-14
Recruiting
Peter MacCallum Cancer Centre, Australia
Phase 2
92
St Leonards, Melbourne
2023-12-14
Active, closed
Peter MacCallum Cancer Centre, Australia
Phase 1
10
Melbourne
2023-12-08
Recruiting
Peter MacCallum Cancer Centre, Australia
Observational
10
Melbourne
2023-12-01
Active, closed
Peter MacCallum Cancer Centre, Australia
Phase 2
40
Woolloongabba, Bedford Park, Parkville
2023-09-07
Recruiting
Metabolic Phenotypes in Melanoma
NCT05570227Melanoma
Peter MacCallum Cancer Centre, Australia
Not applicable
240
Melbourne
2023-06-27
Active, closed
Deep sequencIng in Cutaneous Squamous CEll caRciNomas
NCT05878288Cutaneous Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma of the Head and Neck, Neoplasms, Non-melanoma Skin Cancer
Peter MacCallum Cancer Centre, Australia
Phase 2
11
Melbourne
2023-05-26
Recruiting
Peter MacCallum Cancer Centre, Australia
Phase 1/2
66
Melbourne
2022-09-29
Active, closed
Combination of Radium-223 and Lutetium-177 PSMA-I&T in Men with Metastatic Castration-Resistant Prostate Cancer
NCT05383079Metastatic Castration-resistant Prostate Cancer, MCRPC, Prostate Cancer
DrugXofigo
Peter MacCallum Cancer Centre, Australia
Phase 1/2
36
Melbourne
2022-09-13
Active, closed
Peter MacCallum Cancer Centre, Australia
Phase 1/2
35
Sydney, Melbourne
2022-07-14
Recruiting
Diagnosis and Phenotype Characterisation Using Genomics in Patients With Inherited Bone Marrow Failure (IBMDx Study)
NCT05196789Inherited BMF Syndrome, Inherited Platelet Disorder, Hematologic Diseases
Peter MacCallum Cancer Centre, Australia
Observational
350
Melbourne
2022-03-18
Active, closed
Peter MacCallum Cancer Centre, Australia
Phase 3
660
Sydney, Brisbane, Adelaide, Melbourne
2022-03-02
Recruiting
Peter MacCallum Cancer Centre, Australia
Phase 1
24
Melbourne
2021-12-08
Active, closed
ProsTIC Registry of Men Treated With PSMA Theranostics
NCT04769817Prostate Cancer, Metastatic Castration-resistant Prostate Cancer
Peter MacCallum Cancer Centre, Australia
Observational
500
Melbourne
2021-05-19
Active, closed
Peter MacCallum Cancer Centre, Australia
Phase 1/2
20
Melbourne
2020-08-06
Active, closed
Peter MacCallum Cancer Centre, Australia
Phase 2
130
Liverpool, St Leonards, Sydney, Brisbane, Adelaide, Malvern, Melbourne, Prahran
2020-04-21
Active, closed
Peter MacCallum Cancer Centre, Australia
Phase 2
20
Melbourne
2020-04-07
Active, closed
Peter MacCallum Cancer Centre, Australia
Phase 1/2
50
Townsville, Melbourne, Nedlands
2019-08-19
Active, closed
177Lu-PSMA-617 Therapy and Olaparib in Patients With Metastatic Castration Resistant Prostate Cancer
NCT03874884Metastatic Castration Resistant Prostate Cancer (mCRPC)
Peter MacCallum Cancer Centre, Australia
Phase 1
70
Sydney, Melbourne
2019-07-09
Rows per page Showing 1–31 of 31
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 19 November 2026. https://priyalifescience.com/clinical-trials-australia

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,379 studies in total at the last sync on 18 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 31 of those studies that match the filters currently applied.

How many clinical trials are recruiting in Australia?

13 of the 31 studies on this page are recruiting new participants as of the 18 Nov 2026, 03:18 UTC sync. A further 5 have not yet opened recruitment, 13 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase, 31 studies
PhaseStudiesRecruitingShare
Phase 210432.3%
Not applicable5316.1%
Observational5316.1%
Phase 15216.1%
Phase 1/25116.1%
Phase 3103.2%

Most active sponsors

Lead sponsors with the most studies
Lead sponsorStudiesRecruiting
Peter MacCallum Cancer Centre, Australia3113

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Prostate Cancer (4) Metastatic Castration-resistant Prostate Cancer (4) Relapsed/Refractory Large B-cell Lymphoma (1) Mantle Cell Lymphoma Refractory (1) Oral Mucositis (1) Chronic Lymphocytic Leukemia (1) Melanoma (1) Metastatic Castration Resistant Prostate Cancer (mCRPC) (1) Neuroendocrine Tumors (1) mCRPC (1) Follicular Lymphoma (1) Relapsed/Refractory Multiple Myeloma (1) Prostatic Neoplasms (1) Melanoma (Skin Cancer) (1) Cancer of Unknown Primary (1)
→

Browse trials by site location

Melbourne (30) Sydney (6) Brisbane (3) Adelaide (3) Camperdown (2) Nedlands (2) St Leonards (2) Westmead (1) Herston (1) Murdoch (1) Woolloongabba (1) Bedford Park (1) Parkville (1) Townsville (1) Cairns (1)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.